Fredericksburg Free Lance Star Drug slows Alzheimer's but can it make a real difference? Northern Virginia • Nov 30, 2022
Daily Mail on Virginia U.S. Supreme Court turns away Biogen bid to reinstate MS drug patent Virginia Non-Local Sources • Oct 3, 2022
Fredericksburg Free Lance Star Alzheimer's drug shows promise in early results of study Northern Virginia • Sep 28, 2022
Times-Dispatch | Business Alzheimer's drug shows promise in early results of study Virginia Business • Sep 28, 2022
Times-Dispatch | Business Biogen pays $900M to settle doctor kickback allegations Virginia Business • Sep 27, 2022
Fredericksburg Free Lance Star Biogen pays $900M to settle doctor kickback allegations Northern Virginia • Sep 27, 2022
Times-Dispatch | Business Good News for Retirees: Lower Medicare Part B Premiums Could Be Coming Virginia Business • Jul 31, 2022
Times-Dispatch | Business Change at the top for Biogen after Alzheimer's drug flops Virginia Business • May 3, 2022
Fredericksburg Free Lance Star Change at the top for Biogen after Alzheimer's drug flops Northern Virginia • May 3, 2022
Fredericksburg Free Lance Star Biogen's 2022 outlook leaves investors wanting, shares slip Northern Virginia • Feb 3, 2022
Fredericksburg Free Lance Star Biogen tumbles after Medicare lays out Aduhelm coverage plan Northern Virginia • Jan 12, 2022
Inside Nova Woodbridge Biogen Cuts Price of Controversial Aduhelm in Half Northern Virginia • Dec 21, 2021
Times-Dispatch | Business Biogen CEO: 'Major bottleneck' still limits Alzheimer's drug Virginia Business • Oct 20, 2021
Daily Mail on Virginia Boston scientist, 38, who flew from US to her native China while infected with COVID-19 in March and took medication to mask her symptoms, is handed a suspended... Virginia Non-Local Sources • Jan 26, 2021
Daily Mail on Virginia Biogen conference attended by 175 people in Boston in February is linked to up to 330,000 coronavirus infections in 29 states and three other countries Virginia Non-Local Sources • Dec 11, 2020
Daily Mail on Virginia U.S. court rules in favor of Mylan over Biogen's key MS drug patent Virginia Non-Local Sources • Jun 18, 2020
Times-Dispatch | Business Biogen reanalyzes studies, presses ahead on Alzheimer's drug Virginia Business • Oct 22, 2019
Fredericksburg Free Lance Star Biogen reanalyzes studies, presses ahead on Alzheimer's drug Northern Virginia • Oct 22, 2019
Times-Dispatch | Business US stocks edge higher on company earnings; Biogen surges Virginia Business • Oct 22, 2019
Times-Dispatch | Business Company says it will seek approval of Alzheimer's drug Virginia Business • Oct 22, 2019
Fredericksburg Free Lance Star Company says it will seek approval of Alzheimer's drug Northern Virginia • Oct 22, 2019